Canopy Growth (CGC) Net Margin Growth (3y) (2022 - 2026)
Canopy Growth (CGC) Net Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | 3,270.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,077.00 |
| Sep 30, 2025 | 11,687.00 |
| Sep 30, 2024 | 1,760.00 |
| Jun 30, 2024 | -28,319.00 |
| Mar 31, 2024 | 7,788.00 |
| Dec 31, 2023 | 478,874.00 |
| Sep 30, 2023 | -18,243.00 |
| Jun 30, 2023 | 6,672.00 |
| Mar 31, 2023 | 130,602.00 |
| Dec 31, 2022 | 4,435.00 |
| Sep 30, 2022 | -44,106.00 |
| Jun 30, 2022 | -154,824.00 |
| Mar 31, 2022 | 23,619.00 |